Showing results (1401-1410 of 1,479) with videos related to

Sort By:
Pageof 148
Annals of Neurology|June 4, 2019
A metabolic profile of polyamines in parkinson disease: A promising biomarkerShinji Saiki, Yukiko Sasazawa, Motoki Fujimaki, et al.
Frontiers in Plant Science|June 17, 2021
Deciphering OPDA Signaling Components in the Momilactone-Producing Moss Calohypnum plumiformeHideo Inagaki, Koji Miyamoto, Noriko Ando, et al.
Inorganic Chemistry|December 5, 2015
Electronic Structure of a Mixed-Metal Fluoride-Centered Triangle Complex: A Potential Qubit ComponentJames P S Walsh, Sarah B Meadows, Alberto Ghirri, et al.
Nature Communications|February 9, 2023
Enhanced charge density wave with mobile superconducting vortices in La1.885Sr0.115CuO4J-J Wen, W He, H Jang, et al.
NPJ Regenerative Medicine|March 31, 2021
Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosisSuguru Takeuchi, Atsunori Tsuchiya, Takahiro Iwasawa, et al.
Rheumatology (Oxford, England)|June 25, 2025
Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity stateEmi Nakanishi, Masakazu Matsushita, Kentaro Minowa, et al.
Cancer Medicine|December 22, 2023
Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysisTakanori Suzuki, Kentaro Matsuura, Yuta Suzuki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 3, 2022
Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivationTakanori Suzuki, Kentaro Matsuura, Kenji Urakabe, et al.
Plos One|September 19, 2023
Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccinationToshihiro Takahashi, Tomohiko Ai, Kaori Saito, et al.
Oncology|July 7, 2025
The Neutrophil-to-Lymphocyte Ratio during Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma Predicts Long-Term Therapeutic Efficacy: A Multicenter AnalysisRyo Sato, Takanori Suzuki, Kentaro Matsuura, et al.
Pageof 148